Design, synthesis and biological evaluation of new ganglioside GM3 analogues as potential agents for cancer therapy - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2020

Design, synthesis and biological evaluation of new ganglioside GM3 analogues as potential agents for cancer therapy

Résumé

Ganglioside GM3 is well known as a tumor-associated carbohydrate antigen on several types of tumors. Many studies have demonstrated that GM3 plays roles in cells proliferation, adhesion, motility and differentiation, which is involved in the process of cancer development. In the present study, we developed methods to synthesize GM3 analogues conveniently. By enzymatic hydrolysis and chemical procedures, two novel analogues and two known analogues were synthesized, containing lactose and glucosamine. Then anti-proliferation and anti-migration activities were evaluated by cytotoxicity assays and wound healing tests, and the data demonstrated that these analogues exhibited anticancer activities. Based on our previous studies, the structure-activity relationships were discussed. This study could provide valuable sight to find new antitumor agents for cancer therapy.
Fichier principal
Vignette du fichier
Revised Manuscript.pdf (716.68 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02985998 , version 1 (02-11-2020)

Identifiants

Citer

Changping Zheng, Ruyi Huang, Teodora Bavaro, Marco Terreni, Matthieu Sollogoub, et al.. Design, synthesis and biological evaluation of new ganglioside GM3 analogues as potential agents for cancer therapy. European Journal of Medicinal Chemistry, 2020, 189, pp.112065. ⟨10.1016/j.ejmech.2020.112065⟩. ⟨hal-02985998⟩
69 Consultations
110 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More